Align Probiotic and Alison Sweeney Transform Classic NYC Streetscapes Into Unmissable Messages About Gut Health
NEW YORK--(BUSINESS WIRE)--Occasional bloating, gas, and abdominal discomfort are all signs that your gut needs attention. Yet, too often, we ignore the signs our bodies send us. Today, Align Probiotic — the #1 doctor and gastroenterologist recommended probiotic brand ‡ — is teaming up with award-winning actress and health advocate Alison Sweeney to make gut health impossible to overlook by creatively altering everyday New York City sights into powerful reminders to listen to your body.
This unique activation will take place at the Oculus Plaza, where Align Probiotic will transform common NYC street elements into bold, attention-grabbing displays about digestive health. Visitors will encounter classic city fixtures strikingly reimagined as signs that it's time to pay more attention to your gut health: a street sign named "Bloating Ave," a park bench and a newspaper box vandalized with graffiti messages like "Gas" and "Bloating." The immersive installation will also feature local taxi cabs and a souvenir pop-up shop filled with items cleverly designed with messages your gut has been trying to tell you. This can't-miss experience serves as a powerful reminder that gut health deserves just as much attention as the signs we see every day. Alison Sweeney will be present at the Oculus Plaza to engage with the public, share her own experiences, and encourage everyone to tune into their gut health.
'Like most people, I'm constantly juggling family and work obligations, often tuning out the little signs my body occasionally gives me,' said Alison Sweeney. 'Together with Align Probiotic, our goal is to ensure people don't dismiss occasional feelings of bloating or discomfort but instead learn to listen to and trust their gut.'
Align Probiotic features a unique strain, B. longum 35624™, which naturally helps maintain digestive balance and relieve occasional bloating and gas.* With this campaign, Align wants to emphasize the importance of taking care of one's gut and encourage consumers to listen to the subtle signals their bodies send every day.
'Occasional digestive issues can hold us back and make us feel uncomfortable. And with busy lifestyles, it's easy to overlook the signs our body is giving us, but there is a point when we realize we might be ignoring an important issue,' said Ryan Parker, Brand Director, Align Probiotic. 'That's why we're here – to help reframe the signs of digestive issues as your inner voice to be trusted. We want to help people see the signs, listen to their body, and take action. If you're experiencing and frustrated by occasional bloating and gas, this is your gut giving you a message. It's a sign that it's time to try Align."
Iconic signs are everywhere, not just in your gut! Align Probiotic is extending the message nationwide by hosting a sweepstakes for a chance to win a trip for two to visit an iconic American 'sign' (Hollywood, Welcome to Las Vegas, or Radio City). To enter, consumers can follow, like and tag a friend in the campaign post on Align Probiotic's Instagram page @AlignProbiotic. The sweepstakes encourages everyone to tune into their gut health, ensuring that this critical wellness priority receives the attention it deserves.
To learn more about Align Probiotic, please visit www.alignprobiotic.com.
ABOUT ALIGN PROBIOTIC
Align Probiotic has a variety of daily probiotic supplements for everyone in the family to help support a healthy digestive system.*
The digestive benefits in our Align 24/7 Digestive Support *§ capsules come from a unique strain of bacteria only found in Align. In the 1990s, a group of gastroenterologists and microbiologists began researching probiotic strains, and they discovered Bifidobacterium 35624™ – which helps relieve occasional bloating, gas, and abdominal discomfort* and is backed by 20+ years of research.
Along with Align 24/7 Digestive Support *§, some of our other most popular products are: Bloating Relief + Food Digestion, which has a probiotic to relieve occasional bloating* and Vitamin B12 to help break down food into cellular energy*; Women's Dual Action, which has probiotics to help support vaginal health and a botanical to help support monthly mood balance*; and DualBiotic gummies which has a prebiotic to help nourish good bacteria and a probiotic to add more good bacteria to the gut*
Even medical experts prefer Align, as it is recommended over 2 times more often than any other probiotic brand by gastroenterologists. ‡
ABOUT PROCTER & GAMBLE
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
‡Among doctors and gastroenterologists who recommended a brand of probiotic in a ProVoice 2024 survey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Barilla: New Research Shows Eating Pasta Can Lift Your Mood
PARMA, Italy--(BUSINESS WIRE)--Recent research conducted in Italy by Università Cattolica del Sacro Cuore, with support from Barilla Group, has explored the psychological and emotional effects of pasta consumption. The research team led by Professor Francesco Pagnini, a clinical psychologist with previous academic affiliations at Harvard University, investigates the relationship between pasta consumption and emotional well-being. The findings, published in the journal Food Science & Nutrition, suggest that pasta consumption is associated with increased happiness, reduced stress, and improved quality of life. The study titled "Pasta, what a feeling! A multi-method study on the relationship between pasta consumption and happiness" used an observational design to examine the unique emotional and psychological effect of pasta. Unlike other foods, the study, with a focus on the Italian market, revealed that pasta seems to boost happiness and reduce stress, particularly when enjoyed in social settings like family dinners or gatherings with friends. The first part of the research involved a sample of 1,532 Italian participants. Data were collected through surveys and reveal that 41% of respondents associate pasta with family, while 21% link it to positive emotions,10% to the pleasure of eating pasta, and 7% to comfort and relaxation. "Our research indicates that the simple act of sharing a pasta meal can create lasting emotional connections and provide comfort like no other," comments Professor Pagnini -'According to this study, no other carbohydrate-based food such as rice, bread, pizza, or other nutritional options is able to trigger such an increase in happiness as pasta when consumed with others. The data suggest that the combination of pasta and social interaction significantly boosts happiness levels." 'This study reaffirms how pasta's delightful taste and nourishing qualities can bring a sense of happiness to everyday life.' says Valeria Rapetti, R&D Global Nutrition and Wellbeing Director of Barilla Group. 'This study beautifully captures how pasta brings people together, creating moments of happiness.' The study underscores the importance of considering the psychological and social dimensions of food consumption, especially pasta, shown by this key data: Pasta is a regular choice for 44% of participants, who enjoy it 2-3 times a week, and nearly 23,9% make it a daily habit. Pasta is linked to feelings of satiety (34%), satisfaction (29%), happiness (10%). Emotional associations include family (41%), positive emotions (21%), and comfort (7%).
Business Wire
2 hours ago
- Business Wire
LegitScript Healthcare Merchant Certification Now Recognized by Google for Telemedicine Providers in the United Kingdom
PORTLAND, Ore.--(BUSINESS WIRE)-- LegitScript, the leader in merchant and product certification and monitoring in the advertising, e-commerce, and payment sectors, today announced its partnership with Google to certify telemedicine providers in the United Kingdom. The policy update means that telemedicine businesses operating in the UK can now apply for LegitScript Healthcare Certification, a required step for advertising their services on Google's platforms. LegitScript's Healthcare Certification provides a trusted pathway for telemedicine businesses to demonstrate compliance and transparency with regulators, the public, and third-party partners. This expansion represents a significant opportunity for telemedicine providers in the United Kingdom to build trust and brand awareness at a time when the industry, which is on a rapid trajectory, is becoming increasingly competitive. The total market revenue of the United Kingdom's telehealth industry is projected to increase from $2.43 billion to $7.55 billion by 2030, with an annual growth rate of 21.1%, according to Grand View Research. As digital-first healthcare delivery models continue to rise, it is essential that telemedicine advertising avenues remain safe, trustworthy, and compliant. 'As Google expands its advertising policies in the United Kingdom, we're collaborating to build a safer, more transparent online ecosystem not only for telemedicine providers, but for patients,' said Angela Salter, Director, Partnerships and Sales at LegitScript. 'This is a truly meaningful step forward in supporting platform integrity and trust while enabling legitimate, verified providers to reach patients who require care.' LegitScript's Healthcare Certification provides a trusted pathway for telemedicine businesses to demonstrate compliance and transparency with regulators, the public, and third-party partners. LegitScript Certification is included within the approval process for conducting card-not-present transactions with Visa and Mastercard, and it is a requirement for many online platforms. Google's policy update now makes it possible for UK-based telemedicine providers to expand their reach by advertising on the world's most popular online ad platform. 'Healthcare is a complex, heavily regulated industry, especially as it becomes increasingly digitized and businesses operate across various jurisdictions,' Salter said. 'LegitScript helps providers avoid inadvertent noncompliance and stay current with regulatory changes to help them access top-tier advertising platforms like Google, maintain crucial access to key payment processing networks, and most importantly, secure the trust of patients and their families.' To learn more about LegitScript's Healthcare Certification program, download the application checklist, and begin the application process, visit: For more details on Google's advertising policies and to stay up to date with changes, visit the Google Ad Policy Change Log homepage. About LegitScript LegitScript, the global leader in Enterprise Risk Management Solutions, is trusted by the world's largest search engines, e-commerce marketplaces, payment service providers, and social media platforms. By combining advanced, AI-driven technology with deep domain expertise and curated market intelligence, LegitScript empowers businesses to stay ahead of emerging threats and seize new growth opportunities with precision and speed. Our global team of regulatory experts and analysts is skilled at understanding global regulatory changes and assessing risk across products, websites, merchants, and platforms, providing clients with unmatched accuracy, actionable insights, and exceptional support.
Yahoo
4 hours ago
- Yahoo
CDC vaccine panel to review ingredient RFK Jr has targeted for removal
A key vaccine advisory panel reconstituted by health secretary and vaccine skeptic Robert F Kennedy Jr is slated to discuss thimerosal-containing influenza vaccines in its first meeting – an ingredient which has been a fixation of anti-vaccine activists for decades. The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) will hold two separate votes later this month: one on 'influenza vaccines' and one on influenza vaccines that contain thimerosal. Thimerosal is an ethylmercury preservative used in multi-dose vaccine vials to prevent fungi and bacteria growth. The preservative has been studied and deemed safe, but was nevertheless removed from all routine childhood vaccines in 2001 as a precaution. 'I was there when we went through this the first time,' said Dr Paul Offit, director of the vaccine education center and an attending physician in the division of infectious diseases at Children's Hospital of Philadelphia, about debates over the preservative in the early 2000s. Offit served on the ACIP panel in question from 1998 to 2003. He said the issue of thimerosal was vigorously debated and found safe then, prompting him to ask: 'What's the point?' In a short history of the thimerosal controversy published in the New England Journal of Medicine, Offit described how some parents became convinced thimerosal gave their children autism, resulting in thousands of autistic children receiving heavy metal chelation treatments each year. Studies have found no link between thimerosal and autism, according to the American Academy of Pediatrics. The National Vaccine Injury Compensation Program has also denied claims of a thimerosal-autism link. Kennedy, however, has written a book arguing against the use of thimerosal. Offit said the discussion of thimerosal appeared to geared to, 'accomplish [Kennedy's] goals of making vaccines less affordable, less accessible and more feared', he said. 'Here's what you do know – you do know RFK Jr is an anti-vaccine, science-denying conspiracy theorist. He is devoted to this, he is a zealot, there is no middle ground with him,' said Offit. 'He believes we have merely substituted infectious diseases for chronic diseases.' The panel's advisory recommendations are critical because they result in vaccine 'schedules'. These schedules are relied on by health insurers to determine which vaccines to cover and by clinicians who use them as an evidence-based guide on immunization – effectively giving the American public access to the medicines. Although the CDC does not always take the panel's advice, the CDC typically affirms the panel's decisions. However, the agency is currently without a leader, as Senate hearings have not yet been held for nominee and CDC career official Susan Monarez. As a result, Kennedy has signed off on some previous ACIP recommendations. Kennedy wrote a book on the preservative thimerosal in 2014 called Thimerosal: Let the Science Speak, in which he argues that 'there is a broad consensus among research scientists that thimerosal is a dangerous neurotoxin that should be immediately removed from medicines'. Kennedy said in the book he is 'pro-vaccine'. Until 9 June, the ACIP was an independent panel of 17 experts who served staggered terms and were rigorously vetted by career CDC staff. Kennedy broke with tradition when he fired the entire panel, claiming in a Wall Street Journal editorial that he was working to 'restore public trust in vaccines'. The same week, Kennedy appointed eight new members to the committee, including medical professionals with little vaccine expertise and known vaccine skeptics. A wide spectrum of groups criticized the decision, from MomsRising, who said they were 'alarmed and disgusted', to major doctors' groups such as the American Academy of Pediatrics, to public health leaders who described Kennedy's actions as 'a coup,' to the former members of the committee, who warned the independent panel was at 'a crossroads'. The group is scheduled to meet the last week of June. Prior to Kennedy's changes, they had been expected to discuss reducing the number of shots needed for human papilloma virus (HPV) and a meningococcal vaccine. On Wednesday, the panel released a draft agenda for its upcoming meeting. A wide range of vaccines will be discussed – including those against influenza; the tropical disease chikungunya; the measles, mumps, rubella and varicella (chickenpox) vaccine; anthrax; Covid and respiratory syncytial virus (RSV). The agenda scheduled a vote on recommendations for flu vaccines, including the multidose versions that still contain thimerosal. These vaccines are used only in adolescents and adults. The panel is also scheduled to vote on recommendations for maternal and pediatric versions of the respiratory syncytial virus (RSV). Notably, despite Kennedy's repeated pledges of 'radical transparency', the draft agenda does not include the names of many speakers, which are listed as 'TBD' (to be determined) for instance on 'Covid-19 safety update'. New ACIP members have not been added to a conflict of interest tracker for ACIP members developed by the Trump administration. A spokesperson for HHS said the new members ethics agreements 'will be made public' before they start work with the committee. In addition to the new draft agenda, there have also been changes to the committee's meeting times not reflected in the Federal Register, according to Politico. The group will meet for two days instead of three, and there does not appear to be a vote scheduled on Covid vaccines.
